Bridgebio Pharma Inc. (bbio 2.25 02/01/29)
13F holders, Q2 2024 (June 30)5holders +1
2new positions
1sold out
$0.80avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Bridgebio Pharma Inc. (bbio 2.25 02/01/29) in their 13F filings, up 1 from Q1 2024. 2 opened new positions and 1 sold out. The largest holders were New York State Common Retirement Fund ($2.3M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.0M) and Jane Street Group, LLC ($560K).
- Company
- Bridgebio Pharma Inc. (bbio 2.25 02/01/29)
- CUSIP
- 10806XAD4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $579K |
| Exits | 1 | $8.2M |
All 13F filers, Q1 2024 → Q2 2024: 724,000 shares bought and 12,883,000 shares sold, net −12,159,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| New York State Common Retirement Fund | 0.00% | Reduce -50.0% | 2,937,000 | $2.3M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,500,000 | $2.0M |
| Jane Street Group, LLC | 0.00% | New | 700,000 | $560K |
| Sei Investments Co. | 0.00% | No change | 156,000 | $124K |
| Choreo, LLC | 0.00% | New | 24,000 | $19K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.25 02/01/29)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.25 02/01/29) the manager owns.